SEC Form 4 · accession 0001019687-15-000955
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Simon Craw
Officer — Executive Vice President
Period of report
Mar 12, 2015
Accepted (ET)
Mar 13, 2015 · 8:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.062 | Mar 12, 2015 | A | 60,000 | A | — | Mar 12, 2025 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F11/4th of the shares underlying such options shall vest on March 12, 2016, and the remaining share in equal monthly installments over a period of three years.